Children with progression of the disease resulting in additional medical therapy (complications) (measured as proportion of participants) · prolonged wet cough in children
Antibiotics probably leads to lower children with progression of the disease resulting in additional… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects of antibiotics · prolonged wet cough in children
Antibiotics showed no clear difference in children experiencing adverse effects of antibiotics (e.g.… compared with placebo (low certainty).
1 finding from 1 review
Treatment failure Need for additional treatment · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in treatment failure Need for additional treatment compared with SCS treatment (moderate certainty).
1 finding from 1 review
Relapse New acute exacerbation or COPD‐related admission · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in relapse New acute exacerbation or COPD‐related admission compared with SCS treatment (moderate certainty).
1 finding from 1 review
Adverse drug effect—hyperglycaemia · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in adverse drug effect—hyperglycaemia compared with SCS treatment (moderate certainty).
1 finding from 1 review
Adverse drug effects Gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in adverse drug effects Gastrointestinal tract bleeding, symptomatic… compared with SCS treatment (low certainty).
1 finding from 1 review
All‐cause mortality · exacerbations of COPD
SCS treatment for 7 or fewer days showed no clear difference in mortality compared with SCS treatment (moderate certainty).
1 finding from 1 review
Length of hospitalisation (days) · exacerbations of COPD
1 finding from 1 review
FEV1 · exacerbations of COPD
1 finding from 1 review
QoL · exacerbations of COPD
1 finding from 1 review
Intervention not reported
Adults and adolescents · adults and children with chronic asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Asthma‐related non‐fatal SAEc · adults and children with chronic asthma
The intervention showed no clear difference in asthma‐related non‐fatal SAEc (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · adults and children with chronic asthma
The intervention showed no clear difference in all‐cause mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause non‐fatal SAEc · adults and children with chronic asthma
The intervention showed no clear difference in all‐cause non‐fatal SAEc (moderate certainty).
1 finding from 1 review
Intervention not reported
Asthma‐related mortality · adults and children with chronic asthma
1 finding from 1 review
Intervention not reported
Asthma‐related non‐fatal SAEc · adults and children with chronic asthma
The intervention showed no clear difference in asthma‐related non‐fatal SAEc (low certainty).
1 finding from 1 review
Intervention not reported
Children · adults and children with chronic asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · adults and children with chronic asthma
1 finding from 1 review
Intervention not reported
All‐cause non‐fatal SAEc · adults and children with chronic asthma
The intervention showed no clear difference in all‐cause non‐fatal SAEc (moderate certainty).
1 finding from 1 review
Intervention not reported
Asthma‐related mortality · adults and children with chronic asthma
1 finding from 1 review